Zhao L, Tao F, Cheng Z, Lu Y, et al. Predicting 10-year risk of type 2 diabetes in Chinese people with overweight or obesity treated with Tirzepatide: Post hoc analysis of SURMOUNT-CN trial. Diabetes Obes Metab 2025 May 6. doi: 10.1111/dom.16439.
PMID: 40329666